Exogenous nitric oxide increases basal leg glucose uptake in humans

William J. Durham, Catherine W. Yeckel, Sharon L. Miller, Dennis Gore, Robert R. Wolfe

Research output: Contribution to journalArticle

16 Scopus citations


This study addressed the role of blood flow and nitric oxide in leg glucose uptake. Seven subjects (5 men, 2 women) were studied during conditions of resting blood flow and increased blood flow, achieved by infusion of the nitric oxide (NO) donor sodium nitroprusside (SNP) into the femoral artery. Femoral arterial and venous blood samples were obtained and blood flow was determined by infusion of indocyanine green dye. SNP infusion significantly increased leg blood flow (769 ± 103 v 450 ± 65 mL.min-1.leg-1, P < .001), but did not affect arterial (4.68 ± 0.13 mmol/L control, 4.63 ± 0.09 mmol/L SNP) or venous (4.60 ± 0.14 mmol/L control, 4.54 ± 0.10 mmol/L SNP) glucose concentrations. Glucose uptake was significantly (P < .01) higher during SNP infusion (65 ± 6 μmol.min-1.leg-1) than during the basal period (34 ± 6 μmol.min-1.leg-1), whereas lactate release was unaffected (rest, 45 ± 11 μmol.min-1.leg-1; SNP, 42 ± 14 μmol.min-1.leg-1). We conclude that blood flow and/or NO increase basal leg glucose uptake.

Original languageEnglish (US)
Pages (from-to)662-665
Number of pages4
JournalMetabolism: Clinical and Experimental
Issue number6
StatePublished - Jun 1 2003
Externally publishedYes


ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this